Press Releases about Immunoprecise Antibodies Ltd
![](https://mms.businesswire.com/media/20240627304070/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240625615288/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240612313286/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240610639834/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240604502257/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240328426956/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240320099936/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240314074244/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240307470977/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240304754427/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20231214533143/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20231208944275/en/1747961/5/IPA_Logo_01-03-2023.jpg)
IPA Announces Closing of $1.265 Million Public Offering of Common Shares
December 08, 2023
Via Business Wire
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20231206054223/en/1747961/5/IPA_Logo_01-03-2023.jpg)
IPA Announces Pricing of $1.1 Million Public Offering of Common Shares
December 06, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231205313002/en/1747961/5/IPA_Logo_01-03-2023.jpg)
IPA Announces Proposed Public Offering of Common Shares
December 05, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231127562186/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20231113700781/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20231025963840/en/1747961/5/IPA_Logo_01-03-2023.jpg)
IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
October 25, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231023188455/en/1747961/5/IPA_Logo_01-03-2023.jpg)
Via Business Wire
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20230919924394/en/1747961/5/IPA_Logo_01-03-2023.jpg)
ImmunoPrecise Antibodies Announces CFO Transition
September 19, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230914565253/en/1747961/5/IPA_Logo_01-03-2023.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.